All patients
invasive ventilation no oxygen needed non invasive oxygen
dexamethasone in COVID 19 hospitalized - Summary of results Outcome TE 95% CI n k I2 ROB Pub. bias death D28detailed results Jamaati, 2021 1.19 [0.38; 3.72]
1.19 [0.38 ; 3.72 ] Jamaati, 2021 1 0% 50 NA not evaluable deathsdetailed results CODEX (Tomazini), 2020 0.97 [0.72; 1.31]
DEXA-COVID19, 2020 2.00 [0.21; 18.87]
Jamaati, 2021 1.19 [0.38; 3.72]
RECOVERY dexamethasone, 2020 0.83 [0.75; 0.92]
0.85 [0.77 ; 0.94 ] CODEX (Tomazini), 2020, DEXA-COVID19, 2020, Jamaati, 2021, RECOVERY dexamethasone, 2020 4 0% 6,793 moderate not evaluable clinical deteriorationdetailed results CODEX (Tomazini), 2020 0.66 [0.43; 1.02]
0.66 [0.43 ; 1.02 ] CODEX (Tomazini), 2020 1 0% 299 NA not evaluable death or ventilationdetailed results RECOVERY dexamethasone, 2020 0.92 [0.84; 1.01]
0.92 [0.84 ; 1.01 ] RECOVERY dexamethasone, 2020 1 0% 5,418 NA not evaluable hospital dischargedetailed results RECOVERY dexamethasone, 2020 1.10 [1.03; 1.17]
1.10 [1.03 ; 1.17 ] RECOVERY dexamethasone, 2020 1 0% 6,425 NA not evaluable mechanical ventilationdetailed results Jamaati, 2021 1.38 [0.45; 4.20]
RECOVERY dexamethasone, 2020 0.77 [0.62; 0.95]
0.79 [0.63 ; 0.99 ] Jamaati, 2021, RECOVERY dexamethasone, 2020 2 1% 5,468 moderate not evaluable radiologic improvement (14-day)detailed results Jamaati, 2021 4.89 [1.15; 20.79]
4.89 [1.15 ; 20.79 ] Jamaati, 2021 1 0% 50 NA not evaluable serious adverse eventsdetailed results CODEX (Tomazini), 2020 0.53 [0.17; 1.62]
0.53 [0.17 ; 1.62 ] CODEX (Tomazini), 2020 1 0% 299 NA not evaluable 0.2 10.0 1.0 relative treatment effect www.metaEvidence.org 2025-03-09 03:57 +01:00
TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers);
k: number of studies; n: total number of patients;
ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
pathologies: 95,94,90,91
- treatments: 666,1149,1150
- roots T: 290
